Divi’s was established in the year 1990 in Hyderabad, India with two manufacturing units. The laboratory is listed among the top pharmaceutical companies in India. The company is engaged in the manufacture of leading generic compounds and custom synthesis of APIs and intermediates for global innovator companies. The company has four manufacturing facilities and a market presence across several countries.
The R&D team at Divi’s is engaged in developing non-infringing processes attaining commercially viable price throughout the lifecycle of the product, infiltrating continuous process improvements.
Divi’s currently operates two manufacturing locations that are compliant with global regulatory standards and capable of producing annual requirements ranging from 10’s of kilos to 1000’s of tons.
Divi’s complies with cGMP guidelines for both the manufacturing units, having been inspected numerous times by FDA, EU GMP , HEALTH CANADA, TGA, ANVISA , COFEPRIS, PMDA and MFDS health authorities.